SEC Form D · filed February 6, 2023
ZETAGEN THERAPEUTICS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Peter B. Finn · Boston, MAExecJoshua Resnick · Boston, MAExec · DirectorNikhil Thakur, Md · Andover, MAExec · DirectorSteven Sordello · New York, NYDirectorSteve Wolin · Minneapolis, MNDirectorDonald C. Brown · Hopkinton, MADirectorMichael J. Stark · Menlo Park, CADirectorJoe C. Loy · Weatherford, TXDirectorHans Miller · Arlington, VAExecWilliam O. White · Baltimore, MDDirectorTodd Crow · Portland, ORDirectorGregory M. Gentile · New York, NYDirectorRichard C. Warburg · Bethesda, MDDirectorRobert Poulin · Arlington, VAExec · DirectorAndrew Levin · Boston, MAExecNicholas Bienstock · New York, NYDirectorAshok C. Kaveeshwar · Bethesda, MDDirectorMichael D. Hankin · Baltimore, MDDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗